238 related articles for article (PubMed ID: 27428295)
1. Coadministration of VDR and RXR agonists synergistically alleviates atherosclerosis through inhibition of oxidative stress: An in vivo and in vitro study.
Lin LM; Peng F; Liu YP; Chai DJ; Ning RB; Xu CS; Lin JX
Atherosclerosis; 2016 Aug; 251():273-281. PubMed ID: 27428295
[TBL] [Abstract][Full Text] [Related]
2. RXR agonists inhibit high glucose-induced upregulation of inflammation by suppressing activation of the NADPH oxidase-nuclear factor-κB pathway in human endothelial cells.
Ning RB; Zhu J; Chai DJ; Xu CS; Xie H; Lin XY; Zeng JZ; Lin JX
Genet Mol Res; 2013 Dec; 12(4):6692-707. PubMed ID: 24391011
[TBL] [Abstract][Full Text] [Related]
3. RXR agonists inhibit high-glucose-induced oxidative stress by repressing PKC activity in human endothelial cells.
Chai D; Wang B; Shen L; Pu J; Zhang XK; He B
Free Radic Biol Med; 2008 Apr; 44(7):1334-47. PubMed ID: 18206668
[TBL] [Abstract][Full Text] [Related]
4. [Effects and related mechanism of retinoid X receptor agonist bexarotene on atherosclerosis progression in diabetic apoE(-/-) mice].
Zhu J; Xu C; Ning R; Chai D; Lin J
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jun; 42(6):492-7. PubMed ID: 25164224
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
[TBL] [Abstract][Full Text] [Related]
6. Retinoid X receptor-specific ligands synergistically upregulate 1, 25-dihydroxyvitamin D3-dependent transcription in epidermal keratinocytes in vitro and in vivo.
Li XY; Xiao JH; Feng X; Qin L; Voorhees JJ
J Invest Dermatol; 1997 Apr; 108(4):506-12. PubMed ID: 9077482
[TBL] [Abstract][Full Text] [Related]
7. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
9. A naturally occurring rexinoid, honokiol, can serve as a regulator of various retinoid x receptor heterodimers.
Kotani H; Tanabe H; Mizukami H; Amagaya S; Inoue M
Biol Pharm Bull; 2012; 35(1):1-9. PubMed ID: 22223330
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
[TBL] [Abstract][Full Text] [Related]
12. TSLP expression in the skin is mediated via RARγ-RXR pathways.
Mihály J; Gericke J; Lucas R; de Lera AR; Alvarez S; Törőcsik D; Rühl R
Immunobiology; 2016 Feb; 221(2):161-5. PubMed ID: 26531761
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of endoplasmic reticulum stress and oxidative stress by vitamin D in endothelial cells.
Haas MJ; Jafri M; Wehmeier KR; Onstead-Haas LM; Mooradian AD
Free Radic Biol Med; 2016 Oct; 99():1-10. PubMed ID: 27458123
[TBL] [Abstract][Full Text] [Related]
14. RXR agonists inhibit oxidative stress-induced apoptosis in H9c2 rat ventricular cells.
Shan P; Pu J; Yuan A; Shen L; Shen L; Chai D; He B
Biochem Biophys Res Commun; 2008 Oct; 375(4):628-33. PubMed ID: 18755147
[TBL] [Abstract][Full Text] [Related]
15. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
[TBL] [Abstract][Full Text] [Related]
16. Protective Effects of 1,25 Dihydroxyvitamin D3 against High-Glucose-Induced Damage in Human Umbilical Vein Endothelial Cells Involve Activation of Nrf2 Antioxidant Signaling.
Wu M; Wu Y; Xu K; Lin L
J Vasc Res; 2021; 58(4):267-276. PubMed ID: 33946068
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of NF-kappaB on 1,25-dihydroxyvitamin D(3) and retinoid X receptor function.
Farmer PK; He X; Schmitz ML; Rubin J; Nanes MS
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E213-20. PubMed ID: 10893342
[TBL] [Abstract][Full Text] [Related]
18. Retinoid X receptor agonists attenuates cardiomyopathy in streptozotocin-induced type 1 diabetes through LKB1-dependent anti-fibrosis effects.
Chai D; Lin X; Zheng Q; Xu C; Xie H; Ruan Q; Lin J; Liu J; Zeng J
Clin Sci (Lond); 2020 Mar; 134(6):609-628. PubMed ID: 32175563
[TBL] [Abstract][Full Text] [Related]
19. VDR Agonist Prevents Diabetic Endothelial Dysfunction through Inhibition of Prolyl Isomerase-1-Mediated Mitochondrial Oxidative Stress and Inflammation.
Zhang M; Lin L; Xu C; Chai D; Peng F; Lin J
Oxid Med Cell Longev; 2018; 2018():1714896. PubMed ID: 29849865
[TBL] [Abstract][Full Text] [Related]
20. Role of vitamin D3 receptor in the synergistic differentiation of WEHI-3B leukemia cells by vitamin D3 and retinoic acid.
Li J; Finch RA; Sartorelli AC
Exp Cell Res; 1999 Jun; 249(2):279-90. PubMed ID: 10366427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
